Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Sandra Tuyaerts actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Onderzoeksoutput
-
159P Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma
De Jaeghere, E., Tuyaerts, S., Van Nuffel, A., Lippens, L., Hendrix, A., Vuylsteke, P., trinh, X. B., Van Dam, P. A., Aspeslagh, S., De Caluwé, A., Naert, E., Van de Vijver, K., Amant, F., Vandecasteele, K. & Denys, H., dec 2021, In : Annals of Oncology. 32, suppl 7, blz. 1449-1450 2 blz.Onderzoeksoutput: Article
Open Access -
Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?
Baiden-Amissah, R. E. M., Annibali, D., Tuyaerts, S. & Amant, F., 7 aug 2021, In : Cancers. 13, 16, 17 blz., 3988.Onderzoeksoutput: Article
Open Access2 Citaten (Scopus) -
Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?
De Wispelaere, W., Annibali, D., Tuyaerts, S., Lambrechts, D. & Amant, F., 1 mei 2021, In : Cancers. 13, 9, 15 blz., 2040.Onderzoeksoutput: Article
Open Access1 Citaat (Scopus) -
S1-28 The oncolytic HSV-1 virus T-VEC induces immunogenic cell death of melanoma cells and efficiently matures monocyte derived as well as BDCA-1+/BDCA-3+ myeloid dendritic cells
De Munck, J., Kalus, P., Smets, H., Broos, K., Tijtgat, J., Van Riet, I., Dufait, I., Schwarze, J. K., Goyvaerts, C., Neyns, B., Tuyaerts, S., Breckpot, K. & Aerts, J., 10 mei 2021.Onderzoeksoutput: Unpublished abstract
-
S2-106 Talimogene laherparepvec (T-VEC)-induced tumor oncolysate as a source of tumor antigens and maturation factors for blood-isolated myeloid dendritic cells
Tijtgat, J., De Munck, J., Dufait, I., Schwarze, J. K., Breckpot, K., Neyns, B., Aerts, J. & Tuyaerts, S., 11 mei 2021.Onderzoeksoutput: Unpublished abstract
Bestand8 Downloads (Pure)
Activiteiten
- 1 Talk or presentation at a conference
-
A phase I clinical trial on intratumoral injection of autologous CD1c (BDCA-1)+ / CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec (T-VEC) in patients with advanced pretreated melanoma
Julia Katharina Schwarze (Presenter), Jens Tijtgat (Contributor), Gil Awada (Contributor), Louise Cras (Contributor), Inès Dufait (Contributor), Ramses Forsyth (Contributor), Sandra Tuyaerts (Contributor), Bart Neyns (Contributor)17 sep 2021Activiteit: Talk or presentation at a conference